Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting
Go back to Fennec Pharmaceuticals Announces New Research Supporting Integration and Use of PEDMARK® at the 2026 ASCO Annual Meeting| (NASDAQ: FENC) | Delayed: 9.07 +0.22 (2.49%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.85 | 52 Week High | $ | |||
| Open | $8.90 | 52 Week Low | $ | |||
| Day High | $9.25 | P/E | N/A | |||
| Day Low | $8.83 | EPS | $ | |||
| Volume | 145,169 | |||||
| Forest Laboratories (NYSE: FRX) | Delayed: 12.00 --0 (-0%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $12.00 | 52 Week High | $100.88 | |||
| Open | $24.87 | 52 Week Low | $64.33 | |||
| Day High | $12.00 | P/E | 20.69 | |||
| Day Low | $12.00 | EPS | $0.58 | |||
| Volume | 20 | |||||
